Lupin

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE326A01037
  • NSEID: LUPIN
  • BSEID: 500257
INR
2,098.00
-2 (-0.1%)
BSENSE

Sep 24, 03:30 PM

BSE+NSE Vol: 5.47 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 641789,
    "name": "Lupin",
    "stock_name": "Lupin",
    "full_name": "Lupin Ltd.",
    "name_url": "stocks-analysis/lupin",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,098.00",
    "chg": -2,
    "chgp": "-0.1%",
    "dir": -1,
    "prev_price": "2,100.00",
    "mcapval": "95,757.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500257,
    "symbol": "LUPIN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE326A01037",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "05:55 AM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": "5.47 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Lupin Ltd. Technical Momentum Shifts Amid Bearish Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-technical-momentum-shifts-amid-bearish-signals-4202901",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LupinLtd_technicaldot_4202901.png",
        "date": "2026-09-24 08:02:25",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish to a more pronounced bearish stance. Recent technical indicators including MACD, RSI, Bollinger Bands, and moving averages signal a cautious outlook for investors, despite the company’s resilient long-term returns compared to the broader Sensex."
      },
      {
        "title": "Lupin Ltd. Forms Death Cross, Signalling Potential Bearish Trend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-forms-death-cross-signalling-potential-bearish-trend-4202749",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LupinLtd_dealthcross_4202749.png",
        "date": "2026-09-23 18:00:27",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has recently formed a Death Cross, a technical indicator where the 50-day moving average crosses below the 200-day moving average. This development signals a potential shift towards a bearish trend, raising concerns about the stock's near-term momentum and long-term strength."
      },
      {
        "title": "Lupin Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lupin-ltd-is-rated-hold-by-marketsmojo-4198053",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LupinLtd_mojoScore_4198053.png",
        "date": "2026-09-19 10:10:04",
        "description": "Lupin Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Lupin Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lupin-ltd-is-rated-hold-by-marketsmojo-4186634",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LupinLtd_mojoScore_4186634.png",
        "date": "2026-09-08 10:10:03",
        "description": "Lupin Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Lupin Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-technical-momentum-shifts-amid-mixed-market-signals-4178565",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LupinLtd_technicaldot_4178565.png",
        "date": "2026-09-02 08:05:20",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bearish stance. Despite a recent downgrade from a Buy to a Hold rating, the stock’s long-term performance remains robust, though short-term indicators suggest caution for investors navigating the current market environment."
      },
      {
        "title": "Lupin Ltd. Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-technical-momentum-shifts-amid-mixed-market-signals-4176802",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/LupinLtd_technicaldot_4176802.png",
        "date": "2026-09-01 08:04:00",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a modest day change of 0.14%, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, Bollinger Bands, and moving averages, prompting a reassessment of its near-term outlook."
      },
      {
        "title": "Lupin Ltd. Declines 0.82%: 2 Key Factors Shaping This Week’s Movement",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-declines-082-2-key-factors-shaping-this-weeks-movement-4174548",
        "imagepath": "",
        "date": "2026-08-29 16:06:33",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>24 Aug:</strong> Stock opens at Rs.2,190.00, declines slightly amid weak market sentiment</p>\n                    <p><strong>25 Aug:</strong> Price dips further to Rs.2,175.00 on increased volume</p>\n                    <p><strong>26 Aug:</strong> Technical momentum shifts to mildly bearish; stock rebounds to Rs.2,191.20</p>\n                    <p><strong>27 Aug:</strong> Significant open interest surge in derivatives; price falls to Rs.2,164.60</p>\n                    <p><strong>28 Aug:</strong> Week closes at Rs.2,175.00 with modest recovery</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week..."
      },
      {
        "title": "Lupin Ltd. is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/lupin-ltd-is-rated-hold-by-marketsmojo-4173471",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LupinLtd_mojoScore_4173471.png",
        "date": "2026-08-28 10:10:03",
        "description": "Lupin Ltd. is currently rated 'Hold' by MarketsMOJO, with this rating last updated on 14 August 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 28 August 2026, providing investors with the most up-to-date view of the company’s fundamentals and market performance."
      },
      {
        "title": "Lupin Ltd. Sees Significant Open Interest Surge Amidst Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-significant-open-interest-surge-amidst-mixed-market-signals-4171888",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LupinLtd_oi_spurts_by_underlying_4171888.png",
        "date": "2026-08-27 15:00:12",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.3% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this increase, the stock underperformed its sector and broader indices, reflecting a complex interplay of market sentiment and technical factors."
      }
    ],
    "total": 762,
    "sid": "641789",
    "stock_news_url": "https://www.marketsmojo.com/news/lupin-641789"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
      "datetime": "21-Sep-2026",
      "details": "Intimation of allotment of 24111 equity shares under ESOP.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "08-Sep-2026",
      "details": "Intimation about participating in the Analyst/Institutional Investors Meet.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "04-Sep-2026",
      "details": "Lupin Receives U.S. FDA Approval for Modafinil Tablets USP.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has declared <strong>900%</strong> dividend, ex-date: 17 Jul 26",
          "dt": "2026-07-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>2:10</strong> stock split, ex-date: 27 Aug 10",
          "dt": "2010-08-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 11 Aug 06",
          "dt": "2006-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS

21-Sep-2026 | Source : BSE

Intimation of allotment of 24111 equity shares under ESOP.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

08-Sep-2026 | Source : BSE

Intimation about participating in the Analyst/Institutional Investors Meet.

Announcement under Regulation 30 (LODR)-Press Release / Media Release

04-Sep-2026 | Source : BSE

Lupin Receives U.S. FDA Approval for Modafinil Tablets USP.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Lupin Ltd. has declared 900% dividend, ex-date: 17 Jul 26

stock-summary
SPLITS

Lupin Ltd. has announced 2:10 stock split, ex-date: 27 Aug 10

stock-summary
BONUS

Lupin Ltd. has announced 1:1 bonus issue, ex-date: 11 Aug 06

stock-summary
RIGHTS

No Rights history available

Footer loading